Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 5/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7295718 | 0.84 | NAAA (0.60) | NAAASMN1; SMN2ALDH1A1HTTTSHR | |
| SCHEMBL8691439 | 0.81 | NAAA (0.79) | NAAASMN1; SMN2ALDH1A1HTTPRKCA | |
| SCHEMBL4795611 | 0.79 | NAAA (0.61) | NAAASMN1; SMN2ALDH1A1HTTTSHR | |
| SCHEMBL11406577 | 0.78 | NAAA (0.53) | NAAASMN1; SMN2ALDH1A1HTTPRKCA | |
| SCHEMBL4978860 | 0.78 | NAAA (0.86) | NAAASMN1; SMN2ALDH1A1HTTPRKCA | |
| SCHEMBL7287590 | 0.78 | NAAA (0.51) | NAAASMN1; SMN2ALDH1A1PRKCA | |
| SCHEMBL8690525 | 0.76 | NAAA (0.86) | NAAASMN1; SMN2ALDH1A1HTT | |
| SCHEMBL1177076 | 0.76 | NAAA (0.86) | NAAASMN1; SMN2ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL32662564 | 0.76 | NAAA (0.83) | NAAASMN1; SMN2ALDH1A1HTTPRKCA | |
| SCHEMBL4186140 | 0.75 | NAAA (0.56) | NAAASMN1; SMN2ALDH1A1HTTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2940005-B1 | NITRILE COMPOUND, METHOD OF PREPARATION THEREOF AND FRAGRANCE COMPOSITION COMPRISING THE NITRILE COMPOUND | KAO CORP (JP) | 2017-04-05 | — | — | EP | claimed |
| EP-2940005-B1 | NITRILE COMPOUND, METHOD OF PREPARATION THEREOF AND FRAGRANCE COMPOSITION COMPRISING THE NITRILE COMPOUND | KAO CORP (JP) | 2017-04-05 | — | — | EP | disclosed |
| US-9447362-B2 | Nitrile compound | KAO CORPORATION (JP) | 2016-09-20 | — | — | US | disclosed |
| US-20150353480-A1 | NITRILE COMPOUND | KAO CORPORATION (JP) | 2015-12-10 | — | — | US | disclosed |
| EP-2940005-A1 | NITRILE COMPOUND | Kao Corporation (JP) | 2015-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353480-A1 | NITRILE COMPOUND | NOS1, NOS2, NOS3 | NAAA 2568/4885SMN1; SMN2 1160/4885ALDH1A1 551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.